NCT05489211 Study of Dato-DXd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03) Status RECRUITING Phase PHASE2
NCT05061550 Neoadjuvant and Adjuvant Treatment in Resectable Non-small Cell Lung Cancer Status RECRUITING Phase PHASE2
NCT04686305 Phase Ib Study of the Safety of T-DXd and Immunotherapy Agents With and Without Chemotherapy in Advanced or Metastatic HER2+, Non-squamous NSCLC Status RECRUITING Phase PHASE1
NCT04541108 Phase 0 Master Protocol for CIVO Intratumoral Microdosing of Anti-Cancer Therapies Status ACTIVE_NOT_RECRUITING Phase EARLY_PHASE1
NCT04379596 Ph1b/2 Study of the Safety and Efficacy of T-DXd Combinations in Advanced HER2-expressing Gastric Cancer (DESTINY-Gastric03) Status RECRUITING Phase PHASE2